Substituted phenylaminothiazoles and use thereof

US8691850B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Jens-Kerim Ergüden · Uerdingen, DE
• Gunter Karig
• Ulrich Rosentreter · Binnen, DE
• Barbara Albrecht · Wuppertal, DE
• Kerstin Henninger · Wuppertal, DE
• Joachim Hutter · Leverkusen, DE
• Nicole Diedrichs · Wuppertal, DE
• Peter Nell · Wuppertal, DE
• Sabine Arndt · Dortmund, DE
• Walter Hubsch · Wuppertal, DE
• Andreas Knorr · Erkrath, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Dirk Brohm · Mettmann, DE

Key dates

• Filing date: Aug 30, 2005
• Grant date: Apr 8, 2014
• Expiry date: Nov 4, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel phenylaminothiazole derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of hypertension and other cardiovascular disorders.